QIAGEN N.V. (QGEN)
NL0015001WM6 - Common Stock
ChartMill assigns a Buy % Consensus number of 76% to QGEN. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 51.05. This target is 14.28% above the current price.
QGEN was analyzed by 25 analysts. The buy percentage consensus is at 76. So analysts seem to be have mildly positive about QGEN.
In the previous month the buy percentage consensus was at a similar level.
QGEN was analyzed by 25 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-10-17 | HSBC | Downgrade | Buy -> Hold |
| 2024-08-02 | Baird | Maintains | Outperform -> Outperform |
| 2024-06-27 | Wolfe Research | Upgrade | Peer Perform -> Outperform |
| 2024-06-18 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-05-01 | Stifel | Maintains | Hold -> Hold |
| 2024-02-16 | Morgan Stanley | Upgrade | Equal-Weight -> Overweight |
| 2024-02-08 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-02-08 | Citigroup | Maintains | Buy -> Buy |
| 2023-12-20 | JP Morgan | Maintains | Overweight -> Overweight |
| 2023-12-19 | Wells Fargo | Initiate | Equal-Weight |
| 2023-12-13 | Wolfe Research | Initiate | Peer Perform |
| 2023-12-07 | Goldman Sachs | Upgrade | Neutral -> Buy |
| 2023-11-02 | UBS | Maintains | Neutral -> Neutral |
| 2023-10-17 | JP Morgan | Maintains | Overweight -> Overweight |
| 2023-09-26 | Citigroup | Reiterate | Buy -> Buy |
| 2023-09-12 | Baird | Initiate | Outperform |
| 2023-08-09 | UBS | Maintains | Neutral -> Neutral |
| 2023-02-09 | UBS | Maintains | Neutral |
| 2023-02-09 | Citigroup | Maintains | Buy |
| 2022-11-09 | Citigroup | Maintains | Buy |
| 2021-12-14 | Wells Fargo | Maintains | Equal-Weight |
| 2021-10-14 | Redburn Partners | Initiate | Buy |
| 2021-07-14 | Kepler Cheuvreux | Downgrade | Buy -> Hold |
| 2021-06-03 | Goldman Sachs | Initiate | Neutral |